[Bio USA] SK Biopharmaceuticals doubles down on AI, open innovation

Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy?

The company recently wowed investors with clinical trial results.

OpenAI, Anthropic and Amazon are funding RAISE US

OpenAI, Anthropic, Amazon and Microsoft are bankrolling a new nonprofit to retrain American workers for the AI economy. RAISE US, led by Gina Raimondo, has already raised more than 500m. The biggest names in AI agree on at least one thing. The technology they are building could upend the American job market, and almost nobody [] This story continues at The Next Web

AI Giants Back Nonprofit Focused on Workforce Transition

The AI industry's biggest names are investing in more than just models and infrastructure — they're focusing on workforce readiness. OpenAI, Anthropic, Microsoft and Amazon are backing Raise US, a new nonprofit that aims to raise 1 billion to help American workers prepare for an AI-driven economy.

ATE 2026: ‘Don’t use Google, AI apps to replace your physical doctor,’ MedServe CEO warns

The Chief Executive Officer of MedServe, Dr. Tolulope Adewole, has warned Nigerians against relying on artificial intelligence tools for medical diagnosis, insisting that while AI is transforming healthcare, it should never replace consultations with qualified medical professionals. Speaking at the Africa Technology Expo held in Lagos on Friday, Adewole said patients should embrace AI as [] The post ATE 2026: ‘Don’t use Google, AI apps to replace your physical doctor,’ MedServe CEO warns appeared first on Vanguard News.

Why U.S. pharma giants are betting bigger on China's innovation ecosystem?

From AI-assisted high-complexity cardiovascular interventions—where digital algorithms pre-simulate intricate surgical workflows, accurately predict intraoperative risks, and tailor personalized treatment plans to significantly boost procedural efficiency—to AI-powered FFRangio systems that slash measurement time from 20 minutes to just four... As China, the world's second-largest pharmaceutical market, is rapidly transcending its traditional role from a low-cost manufacturing base to a co-developer of cutting-edge therapies and a vital node in global RD networks, an increasing number of multinational pharmaceutical companies are reshaping their investment and partnership strategies on the ground.

The Government Boot Is Coming Down on AI

The Trump administration suddenly has its eye on the AI industry, and Anthropic isn't the only target.

Eli Lilly just placed a $40 million bet on the next injectable boom

The GLP-1 maker’s latest AI investment targets drug discovery and the future of consumer medicine.

Avnet Brings Ecosystem Together to Scale Edge AI in Singapore

As AI adoption accelerates across Singapore and Southeast Asia, where 81 of companies have moved beyond ...

Crinetics Pharmaceuticals: 'Buy' On Palsonify Market Expansion And Atumelnant Advancements

Crinetics Pharmaceuticals: 'Buy' On Palsonify Market Expansion And Atumelnant Advancements

The Last Thing US Healthcare Needs Is an AI Takeover

Karim Sariahmed, Marc Shi We fear that healthcare will become even more financialized as our systems become more deeply entangled with the AI bubble and the speculative investments that accompany it. The post The Last Thing US Healthcare Needs Is an AI Takeover appeared first on The Nation.

AI ubah landskap penjagaan kesihatan negara

KUALA LUMPUR: Penggunaan kecerdasan buatan (AI) dan teknologi digital kini mengubah landskap penjagaan kesihatan negara apabila membolehkan proses diagnosis, rawatan dan pemantauan pesakit dilaksanakan dengan lebih pantas, tepat dan berkesan. Timbalan Menteri Kesihatan, Datuk Hanifah Hajar Taib berkata, perkembangan pesat teknologi kesihatan ketika ini menjadikan sistem penjagaan kesihatan lebih bersifat ramalan dan diperincikan bagi memenuhi ... Read more The post AI ubah landskap penjagaan kesihatan negara appeared first on Utusan Malaysia.

Here Are 4 Major Lawsuits That Have Shaped The Artificial Intelligence Debate

The debate over artificial intelligence has been shaped by several lawsuits since the technology became widespread. In the U.S., major players such as Anthropic and OpenAI vie for the top spot in the industry — all

Is AI’s juice worth the financial squeeze?

Is AI’s juice worth the financial squeeze?

The Bears Say AI Is a Bubble. The Profits Say Otherwise

The single most important issue for the stock market today is determining whether the Artificial Intelligence (AI) revolution will deliver on its promises of boosting productivity and reducing costs. Remember, since Chat-GPT was unveiled by OpenAI in November 2022, AI-related stocks have accounted for 75 of market gains, 80 of market profits, and 95 of []

Building tomorrow’s industries requires building tomorrow’s workforce

Artificial intelligence is transforming the economy at a remarkable speed. Advanced manufacturing is returning to the United States. Biotechnology, quantum computing, and other emerging technologies are creating the industries that will shape the next generation of economic growth. Recent tax reforms encouraging capital investment, restoring research and development expensing, and strengthening advanced manufacturing will help []

Doctor or data? Trust, AI and the rise of misinformation

Sure, you can ask it for a recipe or ideas for a themed birthday party. But in lieu of a health-care provider, maybe that’s when we should draw the line on turning to AI. A recent survey from the Canadian Medical Association found that 97 per cent of doctors had to either step in or [] The post Doctor or data? Trust, AI and the rise of misinformation appeared first on CityNews Montreal.

Most Founders Get This Part of Their Business Plan Wrong—and It Hurts Marketing From Day One

You can build better business plans with cutting-edge AI tools and market better from the start of your launch.

Form 4 Aeon Biopharma Inc For: 22 June

Form 4 Aeon Biopharma Inc For: 22 June

Amazon’s fresh bet signals India’s emergence as global AI hub: experts

Big-tech investment reinforces shift from back office to innovation-led AI ecosystem

If the Market Isn’t ‘Pricing In Promise’ for AI Stocks Anymore—What’s Next for Tech?

If the Market Isn’t ‘Pricing In Promise’ for AI Stocks Anymore—What’s Next for Tech?

Europe’s AI moment: Four imperatives for business leaders

Business in the age of artificial intelligence (AI) moves with dizzying speed. More powerful models launch regularly, bringing new opportunities and risks. Fresh use cases emerge daily, increasingly leaning on the orchestration power of agentic AI. Innovation boundaries recede as the cost of inference declines and robotics accelerates. It’s as if we’re permanently on fast []

AI boom lifts intangible investment to record, UN says

The AI boom has helped drive investments in intangible assets such as software, data and research to a record high in 2025, the United Nations' patent and innovation agency sa...